SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328700. A total of 48 filers reported holding SUNESIS PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 0.57 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $2,010,000 | +59.1% | 1,010,000 | 0.0% | 0.34% | -14.4% |
| Q3 2020 | $1,263,000 | -52.5% | 1,010,000 | -90.0% | 0.40% | -60.3% |
| Q2 2020 | $2,660,000 | -36.5% | 10,100,000 | 0.0% | 1.02% | -44.4% |
| Q1 2020 | $4,190,000 | +22.8% | 10,100,000 | 0.0% | 1.82% | +39.6% |
| Q4 2019 | $3,411,000 | -53.1% | 10,100,000 | 0.0% | 1.31% | -65.5% |
| Q3 2019 | $7,272,000 | +31.1% | 10,100,000 | +32.9% | 3.79% | +60.0% |
| Q2 2019 | $5,548,000 | -39.9% | 7,600,000 | 0.0% | 2.37% | -66.3% |
| Q1 2019 | $9,234,000 | +745.6% | 7,600,000 | +192.3% | 7.03% | +511.1% |
| Q4 2018 | $1,092,000 | – | 2,600,000 | – | 1.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|